Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Recommendations
Coloplast price target raised to DKK 860 from DKK 800 at Berenberg » 13:57
10/16/20
10/16
13:57
10/16/20
13:57
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Berenberg analyst Scott…

Berenberg analyst Scott Bardo raised the firm's price target on Coloplast to DKK 860 from DKK 800 and keeps a Sell rating on the shares.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

09/23/20 Barclays
Coloplast downgraded to Underweight from Equal Weight at Barclays
09/23/20 Jefferies
Coloplast upgraded to Buy from Hold at Jefferies
08/19/20 JPMorgan
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan
08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
Over a month ago
Downgrade
Coloplast downgraded to Underweight from Equal Weight at Barclays » 06:31
09/23/20
09/23
06:31
09/23/20
06:31
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Barclays analyst Hassan…

Barclays analyst Hassan Al-Wakeel downgraded Coloplast to Underweight from Equal Weight with a price target of DKK 895, down from DKK 970. The analyst expects increased investment at Coloplast to generate the same level of growth going forward.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

09/23/20 Jefferies
Coloplast upgraded to Buy from Hold at Jefferies
08/19/20 JPMorgan
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan
08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
Upgrade
Coloplast upgraded to Buy from Hold at Jefferies » 06:25
09/23/20
09/23
06:25
09/23/20
06:25
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Jefferies analyst Kit Lee…

Jefferies analyst Kit Lee upgraded Coloplast to Buy from Hold with a price target of DKK 1,180, up from DKK 800, after an analysis of prescription data on Chronic Care products that showed the company has delivered consistent market share gain and launch success in the last 10 years, which he sees boding well for its 2025 strategy.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

08/19/20 JPMorgan
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan
08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
09/10/20
09/10
04:55
09/10/20
04:55
PHG

Philips

$47.66 /

+0.545 (+1.16%)

, FSNUY

Fresenius SE

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, GGNDF

GN Store Nord

$0.00 /

+ (+0.00%)

, SONVY

Sonova

$0.00 /

+ (+0.00%)

, WILLF

Demant

$0.00 /

+ (+0.00%)

, CZMWY

Carl Zeiss Meditec

$0.00 /

+ (+0.00%)

, AMBBY

Ambu

$0.00 /

+ (+0.00%)

, TCHBF

Tecan

$0.00 /

+ (+0.00%)

, CLPBY

Coloplast

$0.00 /

+ (+0.00%)

, SNN

Smith & Nephew

$40.91 /

+0.73 (+1.82%)

, AMFPF

Amplifon

$0.00 /

+ (+0.00%)

, EKTAY

Elekta

$0.00 /

+ (+0.00%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SAUHY

Straumann

$0.00 /

+ (+0.00%)

, HKMPY

Use HKMPF

$0.00 /

+ (+0.00%)

, GRRMF

Gerresheimer

$0.00 /

+ (+0.00%)

17th European Medtech…

17th European Medtech & Healthcare Services Virtual Conference on September 9-10. Webcast Link

ShowHide Related Items >><<
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

09/02/20
Siemens Healthineers launches cash capital increase
08/02/20
Siemens Healthineers acquires Varian for $177.50 per share or $16.4B
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20
Genentech initiates Phase III clinical trial programs for fenebrutinib, Ocrevus
09/07/20
Blueprint Medicines announces FDA approval of Gavreto
09/04/20
Roche COVID, flu test receives Emergency Use Authorization from FDA
09/01/20
Roche to launch SARS-CoV-2 Rapid Antigen Test
PHG Philips
$47.66 /

+0.545 (+1.16%)

08/31/20
Philips lowers FY20 view after HHS partially terminates ventilator contract
08/27/20
Philips to acquire Intact Vascular for $275M in cash, deferred payments of $85M
08/25/20
Philips, B. Braud receive FDA clearance for Onvision technology
08/25/20
Philips, B. Braun receive FDA clearance for Onvision
PHG Philips
$47.66 /

+0.545 (+1.16%)

09/01/20 UBS
Philips price target lowered to EUR 47 from EUR 48 at UBS
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
07/28/20 Societe Generale
Philips initiated with a Buy at Societe Generale
07/21/20 JPMorgan
Philips price target raised to EUR 39.50 from EUR 36.80 at JPMorgan
FSNUY Fresenius SE
$0.00 /

+ (+0.00%)

08/14/20 JPMorgan
Fresenius SE price target lowered to EUR 60.40 from EUR 66.30 at JPMorgan
08/05/20 Jefferies
Fresenius SE downgraded to Underperform from Hold at Jefferies
07/24/20 Deutsche Bank
Deutsche Bank backs Buy on Fresenius ahead of Q2 results
06/17/20 UBS
Fresenius SE price target lowered to EUR 47 from EUR 49 at UBS
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

09/04/20 DZ Bank
Siemens Healthineers upgraded to Buy from Hold at DZ Bank
08/18/20 UBS
Siemens Healthineers price target raised to EUR 40 from EUR 39 at UBS
08/12/20 Barclays
Siemens Healthineers price target raised to EUR 40 from EUR 38 at Barclays
08/10/20 BTIG
Varian downgraded to Neutral from Buy at BTIG
GGNDF GN Store Nord
$0.00 /

+ (+0.00%)

08/25/20 Morgan Stanley
GN Store Nord price target raised to DKK 414 from DKK 298 at Morgan Stanley
08/20/20 Credit Suisse
GN Store Nord price target raised to DKK 465 from DKK 420 at Credit Suisse
08/20/20 JPMorgan
GN Store Nord price target raised to DKK 413 from DKK 353 at JPMorgan
08/05/20 Credit Suisse
GN Store Nord upgraded to Outperform from Underperform at Credit Suisse
SONVY Sonova
$0.00 /

+ (+0.00%)

09/02/20 UBS
Sonova price target raised to CHF 225 from CHF 220 at UBS
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
07/27/20 Morgan Stanley
Sonova upgraded to Equal Weight from Underweight at Morgan Stanley
WILLF Demant
$0.00 /

+ (+0.00%)

04/17/20 JPMorgan
Demant price target lowered to DKK 145 from DKK 224 at JPMorgan
04/09/20 Jefferies
Demant price target lowered to DKK 195 from DKK 270 at Jefferies
04/09/20 Jefferies
Sonova downgraded to Hold from Buy at Jefferies
01/16/20 Jefferies
Jefferies European team revamps Franchise Picks list with nine additions
CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

07/17/20 Berenberg
Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg
07/16/20 Deutsche Bank
Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
05/26/20 Commerzbank
Carl Zeiss Meditec downgraded to Reduce from Hold at Commerzbank
05/12/20 Deutsche Bank
Deutsche Bank backs Buy on Carl Zeiss Meditec after Q2 results
AMBBY Ambu
$0.00 /

+ (+0.00%)

08/28/20 JPMorgan
Ambu price target lowered to DKK 190 from DKK 219 at JPMorgan
08/27/20 SEB Equities
Ambu upgraded to Buy from Hold at SEB Equities
05/06/20 JPMorgan
Ambu downgraded to Neutral from Overweight at JPMorgan
05/06/20 Danske Bank
Ambu upgraded to Hold from Sell at Danske Bank
TCHBF Tecan
$0.00 /

+ (+0.00%)

08/27/20 Berenberg
Berenberg sees Tecan at 'toppy levels,' downgrades to Hold
08/27/20 Berenberg
Tecan downgraded to Hold from Buy at Berenberg
08/17/20 UBS
Tecan price target raised to CHF 455 from CHF 375 at UBS
08/14/20 Credit Suisse
Tecan price target raised to CHF 425 from CHF 305 at Credit Suisse
CLPBY Coloplast
$0.00 /

+ (+0.00%)

08/19/20 JPMorgan
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan
08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
SNN Smith & Nephew
$40.91 /

+0.73 (+1.82%)

07/31/20 Berenberg
Smith & Nephew price target lowered to 2,090 GBp from 2,150 GBp at Berenberg
07/30/20 JPMorgan
Smith & Nephew price target lowered to 1,553 GBp from 1,633 GBp at JPMorgan
07/30/20 Morgan Stanley
Smith & Nephew price target lowered to 1,940 GBp at Morgan Stanley
07/29/20 BofA
Smith & Nephew upgraded to Buy at BofA as surgical volumes recover
AMFPF Amplifon
$0.00 /

+ (+0.00%)

09/03/20 Jefferies
Amplifon upgraded to Buy from Hold at Jefferies
04/09/20 Jefferies
Amplifon price target lowered to EUR 18.10 from EUR 26 at Jefferies
EKTAY Elekta
$0.00 /

+ (+0.00%)

09/09/20 Morgan Stanley
Elekta price target raised to SEK 91 from SEK 86 at Morgan Stanley
09/03/20 Berenberg
Elekta price target raised to SEK 124 from SEK 100 at Berenberg
08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
SAUHY Straumann
$0.00 /

+ (+0.00%)

08/25/20 UBS
Straumann price target raised to CHF 890 from CHF 800 at UBS
08/24/20 Deutsche Bank
Straumann downgraded to Hold from Buy at Deutsche Bank
08/17/20 Berenberg
Straumann price target raised to CHF 770 from CHF 760 at Berenberg
08/14/20 JPMorgan
Straumann price target raised to CHF 668 from CHF 583 at JPMorgan
HKMPY Use HKMPF
$0.00 /

+ (+0.00%)

04/02/20 JPMorgan
Hikma upgraded to Overweight from Neutral at JPMorgan
02/26/20 H.C. Wainwright
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results
GRRMF Gerresheimer
$0.00 /

+ (+0.00%)

07/29/20 Berenberg
Gerresheimer price target raised to EUR 115 from EUR 75 at Berenberg
SNN Smith & Nephew
$40.91 /

+0.73 (+1.82%)

07/01/20
Smith & Nephew sees Q2 underlying revenue down around 29%
RHHBY Roche
$0.00 /

+ (+0.00%)

07/23/20
Roche confirms outlook for 2020 based on assessment of COVID-19
07/23/20
Roche reports 1H core EPS CHF 10.44 vs. CHF 11.12 last year
07/13/20
Genentech says Phase IIIb STASEY study data reinforces Hemlibra safety profile
04/22/20
Roche confirms outlook for 2020 based on assessment of COVID-19
PHG Philips
$47.66 /

+0.545 (+1.16%)

04/20/20
Philips aims for 'modest comparable sales growth' in FY20
04/20/20
Philips reports Q1 adjusted EPS EUR 0.18 vs. EUR 0.29 a year ago
RHHBY Roche
$0.00 /

+ (+0.00%)

08/06/20
Trump to order government to buy certain drugs from U.S., USA Today says
07/24/20
President Trump expected to sign drug pricing executive orders, WaPo reports
07/06/20
Roche's Genentech loses appeals court bid over Amgen Mvasi, Bloomberg reports
07/06/20
Roche unit loses bid to halt sales of Amgen's Avastin biosimilar, Bloomberg says
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

08/03/20
Fly Intel: Wall Street's top stories for Monday
08/03/20
Fly Intel: Wall Street's top stories at midday
RHHBY Roche
$0.00 /

+ (+0.00%)

08/15/20
Week in review: How Trump's policies moved stocks
08/08/20
Week in review: How Trump's policies moved stocks
08/01/20
Week in review: How Trump's policies moved stocks
07/24/20
Fly Intel: Wall Street's top stories for Friday
PHG Philips
$47.66 /

+0.545 (+1.16%)

09/05/20
Week in review: How Trump's policies moved stocks
09/09/20
17th European Medtech & Healthcare Services Virtual Conference
09/16/20
18th Annual Global Healthcare Virtual Conference
11/23/20
PDUFA Date for Xofluza
Conference/Events
Goldman Sachs to hold a virtual conference » 07:58
09/09/20
09/09
07:58
09/09/20
07:58
PHG

Philips

$47.13 /

+0.48 (+1.03%)

, FSNUY

Fresenius SE

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, GGNDF

GN Store Nord

$0.00 /

+ (+0.00%)

, SONVY

Sonova

$0.00 /

+ (+0.00%)

, WILLF

Demant

$0.00 /

+ (+0.00%)

, CZMWY

Carl Zeiss Meditec

$0.00 /

+ (+0.00%)

, AMBBY

Ambu

$0.00 /

+ (+0.00%)

, TCHBF

Tecan

$0.00 /

+ (+0.00%)

, CLPBY

Coloplast

$0.00 /

+ (+0.00%)

, SNN

Smith & Nephew

$40.18 /

+0.06 (+0.15%)

, AMFPF

Amplifon

$0.00 /

+ (+0.00%)

, EKTAY

Elekta

$0.00 /

+ (+0.00%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SAUHY

Straumann

$0.00 /

+ (+0.00%)

, HKMPY

Use HKMPF

$0.00 /

+ (+0.00%)

, GRRMF

Gerresheimer

$0.00 /

+ (+0.00%)

17th European Medtech…

17th European Medtech & Healthcare Services Virtual Conference on September 9-10. Webcast Link

ShowHide Related Items >><<
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

09/02/20
Siemens Healthineers launches cash capital increase
08/02/20
Siemens Healthineers acquires Varian for $177.50 per share or $16.4B
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20
Genentech initiates Phase III clinical trial programs for fenebrutinib, Ocrevus
09/07/20
Blueprint Medicines announces FDA approval of Gavreto
09/04/20
Roche COVID, flu test receives Emergency Use Authorization from FDA
09/01/20
Roche to launch SARS-CoV-2 Rapid Antigen Test
PHG Philips
$47.13 /

+0.48 (+1.03%)

08/31/20
Philips lowers FY20 view after HHS partially terminates ventilator contract
08/27/20
Philips to acquire Intact Vascular for $275M in cash, deferred payments of $85M
08/25/20
Philips, B. Braud receive FDA clearance for Onvision technology
08/25/20
Philips, B. Braun receive FDA clearance for Onvision
PHG Philips
$47.13 /

+0.48 (+1.03%)

09/01/20 UBS
Philips price target lowered to EUR 47 from EUR 48 at UBS
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
07/28/20 Societe Generale
Philips initiated with a Buy at Societe Generale
07/21/20 JPMorgan
Philips price target raised to EUR 39.50 from EUR 36.80 at JPMorgan
FSNUY Fresenius SE
$0.00 /

+ (+0.00%)

08/14/20 JPMorgan
Fresenius SE price target lowered to EUR 60.40 from EUR 66.30 at JPMorgan
08/05/20 Jefferies
Fresenius SE downgraded to Underperform from Hold at Jefferies
07/24/20 Deutsche Bank
Deutsche Bank backs Buy on Fresenius ahead of Q2 results
06/17/20 UBS
Fresenius SE price target lowered to EUR 47 from EUR 49 at UBS
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

09/04/20 DZ Bank
Siemens Healthineers upgraded to Buy from Hold at DZ Bank
08/18/20 UBS
Siemens Healthineers price target raised to EUR 40 from EUR 39 at UBS
08/12/20 Barclays
Siemens Healthineers price target raised to EUR 40 from EUR 38 at Barclays
08/10/20 BTIG
Varian downgraded to Neutral from Buy at BTIG
GGNDF GN Store Nord
$0.00 /

+ (+0.00%)

08/25/20 Morgan Stanley
GN Store Nord price target raised to DKK 414 from DKK 298 at Morgan Stanley
08/20/20 Credit Suisse
GN Store Nord price target raised to DKK 465 from DKK 420 at Credit Suisse
08/20/20 JPMorgan
GN Store Nord price target raised to DKK 413 from DKK 353 at JPMorgan
08/05/20 Credit Suisse
GN Store Nord upgraded to Outperform from Underperform at Credit Suisse
SONVY Sonova
$0.00 /

+ (+0.00%)

09/02/20 UBS
Sonova price target raised to CHF 225 from CHF 220 at UBS
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
07/27/20 Morgan Stanley
Sonova upgraded to Equal Weight from Underweight at Morgan Stanley
WILLF Demant
$0.00 /

+ (+0.00%)

04/17/20 JPMorgan
Demant price target lowered to DKK 145 from DKK 224 at JPMorgan
04/09/20 Jefferies
Demant price target lowered to DKK 195 from DKK 270 at Jefferies
04/09/20 Jefferies
Sonova downgraded to Hold from Buy at Jefferies
01/16/20 Jefferies
Jefferies European team revamps Franchise Picks list with nine additions
CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

07/17/20 Berenberg
Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg
07/16/20 Deutsche Bank
Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
05/26/20 Commerzbank
Carl Zeiss Meditec downgraded to Reduce from Hold at Commerzbank
05/12/20 Deutsche Bank
Deutsche Bank backs Buy on Carl Zeiss Meditec after Q2 results
AMBBY Ambu
$0.00 /

+ (+0.00%)

08/28/20 JPMorgan
Ambu price target lowered to DKK 190 from DKK 219 at JPMorgan
08/27/20 SEB Equities
Ambu upgraded to Buy from Hold at SEB Equities
05/06/20 JPMorgan
Ambu downgraded to Neutral from Overweight at JPMorgan
05/06/20 Danske Bank
Ambu upgraded to Hold from Sell at Danske Bank
TCHBF Tecan
$0.00 /

+ (+0.00%)

08/27/20 Berenberg
Berenberg sees Tecan at 'toppy levels,' downgrades to Hold
08/27/20 Berenberg
Tecan downgraded to Hold from Buy at Berenberg
08/17/20 UBS
Tecan price target raised to CHF 455 from CHF 375 at UBS
08/14/20 Credit Suisse
Tecan price target raised to CHF 425 from CHF 305 at Credit Suisse
CLPBY Coloplast
$0.00 /

+ (+0.00%)

08/19/20 JPMorgan
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan
08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
SNN Smith & Nephew
$40.18 /

+0.06 (+0.15%)

07/31/20 Berenberg
Smith & Nephew price target lowered to 2,090 GBp from 2,150 GBp at Berenberg
07/30/20 JPMorgan
Smith & Nephew price target lowered to 1,553 GBp from 1,633 GBp at JPMorgan
07/30/20 Morgan Stanley
Smith & Nephew price target lowered to 1,940 GBp at Morgan Stanley
07/29/20 BofA
Smith & Nephew upgraded to Buy at BofA as surgical volumes recover
AMFPF Amplifon
$0.00 /

+ (+0.00%)

09/03/20 Jefferies
Amplifon upgraded to Buy from Hold at Jefferies
04/09/20 Jefferies
Amplifon price target lowered to EUR 18.10 from EUR 26 at Jefferies
09/10/19 Jefferies
Amplifon downgraded to Hold from Buy at Jefferies
EKTAY Elekta
$0.00 /

+ (+0.00%)

09/03/20 Berenberg
Elekta price target raised to SEK 124 from SEK 100 at Berenberg
08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
08/03/20 JPMorgan
Elekta upgraded to Neutral from Underweight at JPMorgan
RHHBY Roche
$0.00 /

+ (+0.00%)

08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
SAUHY Straumann
$0.00 /

+ (+0.00%)

08/25/20 UBS
Straumann price target raised to CHF 890 from CHF 800 at UBS
08/24/20 Deutsche Bank
Straumann downgraded to Hold from Buy at Deutsche Bank
08/17/20 Berenberg
Straumann price target raised to CHF 770 from CHF 760 at Berenberg
08/14/20 JPMorgan
Straumann price target raised to CHF 668 from CHF 583 at JPMorgan
HKMPY Use HKMPF
$0.00 /

+ (+0.00%)

04/02/20 JPMorgan
Hikma upgraded to Overweight from Neutral at JPMorgan
02/26/20 H.C. Wainwright
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results
GRRMF Gerresheimer
$0.00 /

+ (+0.00%)

07/29/20 Berenberg
Gerresheimer price target raised to EUR 115 from EUR 75 at Berenberg
SNN Smith & Nephew
$40.18 /

+0.06 (+0.15%)

07/01/20
Smith & Nephew sees Q2 underlying revenue down around 29%
RHHBY Roche
$0.00 /

+ (+0.00%)

07/23/20
Roche confirms outlook for 2020 based on assessment of COVID-19
07/23/20
Roche reports 1H core EPS CHF 10.44 vs. CHF 11.12 last year
07/13/20
Genentech says Phase IIIb STASEY study data reinforces Hemlibra safety profile
04/22/20
Roche confirms outlook for 2020 based on assessment of COVID-19
PHG Philips
$47.13 /

+0.48 (+1.03%)

04/20/20
Philips aims for 'modest comparable sales growth' in FY20
04/20/20
Philips reports Q1 adjusted EPS EUR 0.18 vs. EUR 0.29 a year ago
RHHBY Roche
$0.00 /

+ (+0.00%)

08/06/20
Trump to order government to buy certain drugs from U.S., USA Today says
07/24/20
President Trump expected to sign drug pricing executive orders, WaPo reports
07/06/20
Roche's Genentech loses appeals court bid over Amgen Mvasi, Bloomberg reports
07/06/20
Roche unit loses bid to halt sales of Amgen's Avastin biosimilar, Bloomberg says
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

08/03/20
Fly Intel: Wall Street's top stories for Monday
08/03/20
Fly Intel: Wall Street's top stories at midday
RHHBY Roche
$0.00 /

+ (+0.00%)

08/15/20
Week in review: How Trump's policies moved stocks
08/08/20
Week in review: How Trump's policies moved stocks
08/01/20
Week in review: How Trump's policies moved stocks
07/24/20
Fly Intel: Wall Street's top stories for Friday
PHG Philips
$47.13 /

+0.48 (+1.03%)

09/05/20
Week in review: How Trump's policies moved stocks
09/09/20
17th European Medtech & Healthcare Services Virtual Conference
09/16/20
18th Annual Global Healthcare Virtual Conference
11/23/20
PDUFA Date for Xofluza
Recommendations
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan » 12:54
08/19/20
08/19
12:54
08/19/20
12:54
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

JPMorgan analyst David Adlington lowered the firm's price target on Coloplast to DKK 886 from DKK 920 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
04/27/20 Barclays
Coloplast price target raised to DKK 930 from DKK 695 at Barclays
Recommendations
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley » 12:24
08/19/20
08/19
12:24
08/19/20
12:24
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Michael Jungling lowered the firm's price target on Coloplast to DKK 822 from DKK 843 and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
04/27/20 Barclays
Coloplast price target raised to DKK 930 from DKK 695 at Barclays
04/20/20 JPMorgan
Coloplast price target raised to DKK 903 from DKK 813 at JPMorgan
Downgrade
Coloplast downgraded to Sell from Hold at Nordea » 05:59
08/11/20
08/11
05:59
08/11/20
05:59
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Nordea analyst Christian…

Nordea analyst Christian Ryom downgraded Coloplast to Sell from Hold with a DKK 930 price target ahead of the company's Q3 report, stating that he expects a miss to position investors for a more cautious outlook in advance of September's CMD.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
04/27/20 Barclays
Coloplast price target raised to DKK 930 from DKK 695 at Barclays
04/20/20 JPMorgan
Coloplast price target raised to DKK 903 from DKK 813 at JPMorgan
03/18/20 JPMorgan
Coloplast upgraded to Neutral from Underweight at JPMorgan
Over a quarter ago
Upgrade
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux » 05:24
05/13/20
05/13
05:24
05/13/20
05:24
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Kepler Cheuvreux analyst Maja Pataki upgraded Coloplast to Hold from Reduce with a DKK 1,083 price target.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

04/27/20 Barclays
Coloplast price target raised to DKK 930 from DKK 695 at Barclays
04/20/20 JPMorgan
Coloplast price target raised to DKK 903 from DKK 813 at JPMorgan
03/18/20 JPMorgan
Coloplast upgraded to Neutral from Underweight at JPMorgan
07/19/19 Barclays
Coloplast downgraded to Equal Weight from Overweight at Barclays
Recommendations
Coloplast price target raised to DKK 930 from DKK 695 at Barclays » 12:13
04/27/20
04/27
12:13
04/27/20
12:13
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Barclays analyst Hassan…

Barclays analyst Hassan Al-Wakeel raised the firm's price target on Coloplast to DKK 930 from DKK 695 and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

04/20/20 JPMorgan
Coloplast price target raised to DKK 903 from DKK 813 at JPMorgan
03/18/20 JPMorgan
Coloplast upgraded to Neutral from Underweight at JPMorgan
07/19/19 Barclays
Coloplast downgraded to Equal Weight from Overweight at Barclays

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.